Search results for "High doses"

showing 10 items of 20 documents

A free radical theory of frailty.

2018

The free radical theory of ageing provided an intellectual framework for many laboratories working on ageing. However, experimental and clinical evidence showing that high doses of antioxidants do not have an effect on ageing or on age-associated diseases, cast doubts on the validity of this theory. Data from our own laboratory show that oxidative damage does not correlate with age, especially in the geriatric population, but rather with the frailty state. This has led us to postulate the free radical theory of frailty that proposes that oxidative damage is associated with frailty, but not with chronological age itself. Superoxide dismutase deficient mice are more frail than controls. But m…

0301 basic medicineOncologymedicine.medical_specialtyAgingFree Radicalsmedicine.disease_causeBiochemistrySuperoxide dismutase03 medical and health sciences0302 clinical medicinePhysiology (medical)Internal medicineDeficient mouseHigh dosesMedicineAnimalsHumansFree-radical theory of agingGeriatricsbiologyFrailtybusiness.industryChronological ageOxidative Stress030104 developmental biologyAgeingbiology.proteinbusiness030217 neurology & neurosurgeryOxidative stressFree radical biologymedicine
researchProduct

Oral high-dose sucrosomial iron vs intravenous iron in sideropenic anemia patients intolerant/refractory to iron sulfate: a multicentric randomized s…

2020

AbstractIron deficiency anemia is among the most frequent causes of disability. Intravenous iron is the quickest way to correct iron deficiency, bypassing the bottleneck of iron intestinal absorption, the only true mechanism of iron balance regulation in human body. Intravenous iron administration is suggested in patients who are refractory/intolerant to oral iron sulfate. However, the intravenous way of iron administration requires several precautions; as the in-hospital administration requires a resuscitation service, as imposed in Europe by the European Medicine Agency, it is very expensive and negatively affects patient’s perceived quality of life. A new oral iron formulation, Sucrosomi…

AdultMalemedicine.medical_specialtyResuscitationIntravenous sodium ferrigluconateAnemiaCost-Benefit AnalysisHigh dosesAdministration OralHigh dose030204 cardiovascular system & hematologyGastroenterologyFerric CompoundsIntestinal absorption03 medical and health scienceschemistry.chemical_compound0302 clinical medicineRefractoryInternal medicineOral Sucrosomial ironMedicineHumans030212 general & internal medicineFerrous CompoundsProspective StudiesAgedAged 80 and overHematologyAnemia Iron-Deficiencybusiness.industryHematologyGeneral MedicineIron deficiencyMiddle Agedmedicine.diseaseIron sulfatechemistryIron-deficiency anemiaIron deficiency anemiaHematinicsAdministration IntravenousFemaleOriginal ArticleRefractoriness/intolerance to oral iron sulfatebusiness
researchProduct

Effects of high doses of toluene on color vision.

1999

High exposure to toluene may cause optic neuropathy and retinopathy, both associated with dyschromatopsia. Another solvent, ethanol, is known to induce acute blue-yellow dyschromatopsia. This study investigated the acute effects of high doses of toluene on color vision. Eight male printshop workers were examined before and after cleaning printing containers with pure toluene. After cleaning, concentrations of toluene in blood were between 3.61 and 7.37 mg/l. Color vision was tested with the Farnsworth panel D-15 test, the Lanthony desaturated panel D-15 test, and the Standard Pseudoisochromatic Plates part 2. For control of possible acute effects, eight workers of a metal-working factory wi…

AdultMalemedicine.medical_specialtygenetic structuresColor visionToxicologyOptic neuropathyCellular and Molecular Neurosciencechemistry.chemical_compoundDevelopmental NeuroscienceOphthalmologyOccupational ExposureHigh dosesMedicineHumansDyschromatopsiaToluene toxicitybusiness.industrymedicine.diseaseTolueneSurgerychemistryAcute exposurePrintingbusinessColor PerceptionRetinopathyTolueneNeurotoxicology and teratology
researchProduct

Microesferas de ácido poliláctico marcadas con 166Ho. Una alternativa frente a las de 90Y en el tratamiento del carcinoma hepático mediante radioembo…

2021

Los tumores hepáticos constituyen un importante problema de salud a nivel mundial que en multitud de ocasiones va asociado a patologías previas y factores de riesgo como las hepatitis víricas B y C, el consumo excesivo de alcohol y el aumento de casos de esteatohepatitis no alcohólica, cada vez más relevante en los países industrializados.En hepatocarcinomas no susceptibles de resección quirúrgica, la braquiterapia se está mostrando muy eficaz frente a la quimioterapia sistémica y transarterial, por lo que se desarrollan nuevos tratamientos locorregionales mínimamente invasivos y con menor toxicidad.La radioembolización hepática es una forma de braquiterapia consistente en la administración…

Chemotherapymedicine.diagnostic_testbusiness.industrymedicine.medical_treatmentBrachytherapyMagnetic resonance imagingViral hepatitis bmedicine.diseaseLower energyMicrospheremedicineHigh dosesSteatohepatitisbusinessNuclear medicineNereis. Interdisciplinary Ibero-American Journal of Methods, Modelling and Simulation.
researchProduct

Minimum effective dose for antidepressants - an obligatory requirement for antidepressant drug evaluation?

1996

Extensive clinical trials are required for registration and approval of new antidepressants in most countries including the requirement that a minimal effective dose should be determined. The rationale for this requirement is to avoid the use of unnecessarily high doses. The implication is that for every antidepressant, a dose exists that serves as a threshold, below which all doses are not effective or are clearly less effective in treating a major depressive episode. Dose titration and fixed dose studies are used to determine the minimal effective dose, but both strategies have limitations and often do not allow definite establishment of a clear-cut minimal effective dose. The effort of e…

Drugmedicine.medical_specialtymedia_common.quotation_subjectComorbidityPharmacologyPharmacokineticsmedicineHigh dosesHumansEthics MedicalPharmacology (medical)Intensive care medicineMajor depressive episodemedia_commonClinical Trials as TopicDepressive DisorderDose-Response Relationship Drugbusiness.industryConfounding Factors EpidemiologicEffective dose (pharmacology)Antidepressive AgentsClinical trialPsychiatry and Mental healthSample size determinationAntidepressantmedicine.symptombusinessInternational Clinical Psychopharmacology
researchProduct

Myelography: current status and post-marketing experience with iotrolan

1995

There are three imaging modalities for the diagnosis of spinal diseases: magnetic resonance imaging (MRI), computed tomography (CT) and myelography. The choice of modality is influenced by factors including diagnostic accuracy cost, radiation dose and invasiveness. For many indications, MRI has advantages over CT and myelography and is the modality of choice, and there is likely to be a trend away from myelographic examinations. In cases where myelography is indicated, it is of prime importance to reduce the frequency and severity of adverse events. During phase III and IV trials, involving over 2000 patients, general and neural tolerance of iotrolan was shown to be significantly better tha…

Iotrolanmedicine.medical_specialtymedicine.diagnostic_testbusiness.industryMagnetic resonance imagingInterventional radiologyGeneral MedicineIopamidolchemistry.chemical_compoundchemistryMetrizamideHigh dosesmedicineRadiology Nuclear Medicine and imagingRadiologyNuclear medicinebusinessMyelographymedicine.drugNeuroradiologyEuropean Radiology
researchProduct

Role of acute social stress in the rewarding effects of MDMA in adolescent mice

2021

Drug use among adolescents is a serious problem in our society, as some individuals develop dependence and addiction. MDMA/Esctasy is one of the most typically used substances by this age group. It is well known that environmental factors can alter the rewarding properties of drugs and the propensity to drug-related disorders. In this sense, exposure to social stress induces long-term effects in mice, enhancing the rewarding effects of MDMA in the conditioned place preference (CPP) paradigm. On the other hand, previous research has not provided conclusive results regarding the short-term effects of social defeat on MDMA reward in adolescent animals, probably due to the use of very low or ve…

MaleN-Methyl-34-methylenedioxyamphetaminemedia_common.quotation_subjectConditioning ClassicalSocial DefeatSocial defeatMice03 medical and health sciencesBehavioral Neuroscience0302 clinical medicineRewardmental disordersHigh dosesAnimalsMedicine030304 developmental biologymedia_commonSocial stress0303 health sciencesBehavior Animalbusiness.industryAddictionAge FactorsMDMAConditioned place preferenceDisease Models AnimalCentral Nervous System StimulantsbusinessStress Psychologicalpsychological phenomena and processes030217 neurology & neurosurgerymedicine.drugClinical psychologyBehavioural Brain Research
researchProduct

The use of high doses of oxycodone in an acute palliative care unit.

2010

A retrospective study of patients who were prescribed controlled-release oxycodone (CRO) in a period of 3 years (2006-2008) was performed. A total of 212 patients were prescribed at discharge CRO for background analgesia; 129, 43, and 40 patients were prescribed doses of oxycodone of less than 120 mg/day (group L), 120 to 240 mg/day (group M), and more than 240 mg/day (group L), respectively. No differences in gender, primary diagnosis, and pain mechanisms were found, but doses were significantly lower in older patients (P < .0005). At discharge, adverse effects were mild and only a minority of patients were switched to other opioids. This study demonstrated that CRO administered in lar…

MalePalliative carePainoxycodoneSettore MED/42 - Igiene Generale E ApplicataNeoplasmsmedicineHigh dosesHumansAdverse effectAgedRetrospective StudiesDose-Response Relationship Drugbusiness.industryPalliative CareAge FactorsRetrospective cohort studyGeneral MedicineMiddle Agedacute palliative care unitoxycodone; acute palliative care unit; trial clinicoAnalgesics OpioidDose–response relationshipDelayed-Action PreparationsAnesthesiaAcute DiseaseMorphineFemaletrial clinicobusinessCancer painOxycodonemedicine.drug
researchProduct

Effects of risperidone on conditioned avoidance responding in male mice

1998

The effects of risperidone (0.1, 0.5 and 1 mg/kg) on active avoidance behaviour of BALB/C mice were explored in three acquisition sessions and in one subsequent performance session. In the acquisition phase, risperidone-treated animals showed a decrease in avoidances and in crossings in the adaptation period and in the intertrial intervals (ITIs), and an increase in non-responses; intermediate and high doses also decreased defecation. In the performance phase, 0.5 and 1 mg/kg risperidone decreased avoidance responses, crossings in the adaptation period and ITI crossing, which also decreased with 0.1 mg/kg. Moreover, 0.5 mg/kg of risperidone increased escape responses and 1 mg/kg increased n…

MalePharmacologyMice Inbred BALB Cmedicine.medical_specialtyRisperidonebusiness.industryMale miceRisperidoneMicePsychiatry and Mental healthEndocrinologyAvoidance behaviourInternal medicineAvoidance LearningmedicineHigh dosesDecreased defecationAnimalsDefecationbusinessPsychomotor PerformanceAntipsychotic Agentsmedicine.drugBehavioural Pharmacology
researchProduct

Equipotent doses to switch from high doses of opioids to transdermal buprenorphine.

2008

INTRODUCTION: The aim of this study was to evaluate the equianalgesic ratio of transdermal buprenorphine (TD BUP) with oral morphine and TD fentanyl in a sample of consecutive cancer patients receiving stable doses of 120-240 mg of oral morphine or 50-100 microg of TD fentanyl, reporting adequate pain and symptom control. MATERIALS, METHODS, AND RESULTS: Patients receiving daily stable doses of opioids for more than 6 days, with no more than two doses of oral morphine (20 and 40 mg, respectively) as needed, were switched to TD BUP using a fentanyl-BUP ratio of 0.6:0.8 and an oral morphine-BUP ratio of 70:1. Opioid doses, pain and symptom intensity, global satisfaction, and number of breakth…

Maletransdermal buprenorphinePainAdministration CutaneousFentanylNeoplasmsHigh dosesMedicineHumansSymptom controlProspective StudiesOral morphineAgedDose-Response Relationship Drugbusiness.industryMiddle AgedEquianalgesicBuprenorphineAnalgesics OpioidFentanylOncologyPatient SatisfactionAnesthesiaFemaleTransdermal Buprenorphinehigh doses of opioidsbusinessCancer painmedicine.drugSupportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
researchProduct